The Consortium of Canadian Centres for Clinical Cognitive Research (C5R) is a non profit collaborative research network that links pharmaceutical companies and researchers collaborating on clinical trials in the desire to research and develop treatments for patients with mild cognitive impairment and dementia.

C5R was founded in 1991 by a group of neurologists, geriatricians and psychiatrists from across Canada, and is the only Canadian consortium conducting trials in dementia and mild cognitive impairment.

Current estimates are that less than 1/3 of dementia patients in North America are correctly diagnosed and only 1/3 of those receive medications.  C5R is a major Canadian group promoting education of physicians on dementia therapy, and disseminating guidelines and treatment standards for the medical community.

Key areas of interest and activities of C5R include supporting best practices, through;

• Development and dissemination of treatment guidelines
• Knowledge translation and continuing education
• Advocacy and health policy support
• Investigator initiated research grants
• Recognition of members’ contribution to the understanding and treatment of patients suffering from cognitive disorders